💨 Abstract

The World Health Organization (WHO) members adopted a treaty to improve pandemic preparedness post-COVID-19, but the U.S.'s absence raises concerns about its effectiveness. The legally binding pact aims to ensure equitable access to drugs, vaccines, and therapeutics during future pandemics, with manufacturers allocating 20% of supplies to the WHO. However, the U.S.,

Courtesy: theprint.in